Hims & Hers Health (HIMS) | Stock Overview & Key Data
Hims & Hers Health Performance Comparison
Stock Range
Today's Range
Low: $50.70
High: $55.10
on September 25, 2025
52 Week Range
Low: $16.05
High: $72.98
on October 3, 2024
on February 19, 2025
All-Time High: $72.98 on February 17, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$12.7B
EPS
0.79
P/E Ratio (TTM)
73.19
Forward P/E
125.70
P/B Ratio
23.20
PEG Ratio
0.34
Div. Yield
N/A
ROE
41.88%
Beta
2.136
Debt to Equity
185.60
Financial Highlights
Profitability
Gross Margin
76.39%
Operating Margin
4.91%
Profit Margin
9.61%
Returns and Earnings
Return on Assets (TTM)
6.94%
Return on Equity (TTM)
41.88%
EBITDA
$154.8M
Net Income (TTM)
$193.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$9.12
Quarterly Revenue Growth (YoY)
72.60%
Quarterly Earnings Growth (YoY)
219.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Hims & Hers Health HIMS | 12.66B Large-cap | 5.76% | 23.87% | 23.98% | 42.34% | 111.31% | 199.66% | 854.30% | 406.66% |
| Procter & Gamble PG | 359.85B Mega-cap | -4.93% | -2.39% | -4.95% | -7.99% | -8.17% | -12.18% | 20.73% | 10.35% |
| Colgate-Palmolive CL | 64.14B Large-cap | -1.33% | -3.49% | -8.00% | -10.75% | -10.40% | -21.73% | 15.49% | 4.82% |
| Kimberly-Clark KMB | 47.73B Large-cap | 1.50% | 9.02% | 1.17% | 2.94% | 9.98% | 7.78% | 9.30% | 3.15% |
| Kenvue KVUE | 33.08B Large-cap | -8.07% | -20.43% | -20.43% | -27.86% | -20.77% | -27.52% | -36.38% | -36.38% |
| Estee Lauder EL | 31.56B Large-cap | -3.22% | -3.78% | 10.75% | 26.51% | 15.34% | -14.56% | -60.48% | -60.99% |
Ownership & Short Interest
Insider Ownership
10.66%
Institutional Ownership
88.99%
Shares Short
75M
Short Ratio
2.41
Short % of Shares Outstanding
40.92%
Average 10-Day Volume
33M
Average 90-Day Volume
27M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HIMS's 52-week high and low?
- In the last 52 weeks, Hims & Hers Health reached a high of $72.98 (on February 19, 2025) and a low of $16.05 (on October 3, 2024).
- What is the market cap and P/E ratio for HIMS?
- Curious about Hims & Hers Health's size and valuation? Its market capitalization stands at 12.66B. When it comes to valuation, the P/E ratio (trailing twelve months) is 73.19, and the forward P/E (looking ahead) is 125.70.
- Does HIMS pay dividends? If so, what's the yield?
- As for dividends, Hims & Hers Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Hims & Hers Health's main competitors or similar companies to consider before investing?
When looking at Hims & Hers Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Procter & Gamble
PG359.85B Consumer Defensive Household & Personal Products -12.18% 20.73% Colgate-Palmolive
CL64.14B Consumer Defensive Household & Personal Products -21.73% 15.49% Kimberly-Clark
KMB47.73B Consumer Defensive Household & Personal Products 7.78% 9.30% Kenvue
KVUE33.08B Consumer Defensive Household & Personal Products -27.52% -36.38% Estee Lauder
EL31.56B Consumer Defensive Household & Personal Products -14.56% -60.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hims & Hers Health, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Hims & Hers Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 41.88%, the Debt to Equity ratio from the most recent quarter is 185.60, and its Gross Profit Margin stands at 76.39%.
- What is the recent revenue and earnings growth for HIMS?
- Looking at Hims & Hers Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 72.60%, and quarterly earnings saw a YoY growth of 219.70%.
- How much of HIMS stock is held by insiders and institutions?
- Wondering who owns Hims & Hers Health stock? Company insiders (like executives and directors) hold about 10.66% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 88.99%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.